0:00
/

OCBC Downgraded, But the Target Price Went Up?

Your bank rally looks good on paper, but what did it do to your dividends?

In this episode I walk Angela through something that should not happen in a “safe” income stock, OCBC getting downgraded on the same day its target price was raised. We break down why CGSI’s new S$28.40 target still translates into a hold when the share price is already above it, and how that sharp run has turned OCBC into the weakest dividend engine among the three local banks. I also explain Citi’s warning on UOB’s asset quality story, and why I am keeping UOB in Preliminary status until August earnings force the real numbers into the open. If you are sitting in Bedok or Jurong with CPF and SRS inside DBS, OCBC, and UOB, this is a kopitiam-level walkthrough of what the brokers are really saying about your future cashflow.

Key takeaways:

  • CGSI raised OCBC’s target to S$28.40, then downgraded it to hold because the price already ran past their valuation.

  • OCBC’s forward dividend yield is now around 3.2%, versus roughly 4.8% for DBS and 4.5% for UOB, making it the weakest income source of the three.

  • Citi put UOB on a 30 day downside catalyst watch, warning the market is overly optimistic on an asset quality turnaround.

  • We map how HSBC Indonesia’s integration timing pushes real ROE expansion for OCBC out to around FY2028, not next quarter.

  • I show why a rising bank share price can quietly hurt your retirement income story if you ignore the yield compression.

The Investing Iguana’s Substack is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.


Iggy’s Forensic Disclaimer

This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.

Discussion about this video

User's avatar

Ready for more?